BioCurate and Takeda renew partnership ‘to create transformational therapies for patients’

Pharma News: The pioneering collaboration between The University of Melbourne and Monash University, BioCurate, has officially renewed its partnership with the global pharmaceutical giant, Takeda. The strategic alliance is set to revolutionise the landscape of early-stage therapeutic research, promising significant advancements in medical treatment.

This partnership marks a significant milestone for both entities, exponentially enhancing their scientific and commercialisation capabilities. The collaboration will grant them increased access to potential projects in critical therapeutic areas, presenting an opportunity for co-investment and further research. This strategic move aims to bolster their ability to identify and push forward the most promising projects in their quest for therapeutic breakthroughs.

In the coming months, the two powerhouses will pool their expertise and resources to tackle challenges hindering the translation and commercialisation of selected projects. This united effort will provide invaluable advice and expertise, streamlining the development process and bringing us one step closer to life-changing therapies.

Dr Eric Hayes, Director of Partnerships at BioCurate, expressed his enthusiasm about the renewed alliance, stating, “We’re thrilled to renew our strategic alliance with Takeda, whose world-class team has a proven track record of successful collaborations to bring new, commercially viable medicines to market. We have some of the world’s best medical research teams operating out of Victoria’s laboratories; Takeda’s expertise will help ensure this research has the best possible chance of becoming therapies that improve people’s lives.”

Dr Michael Martin, Head of Takeda’s Centre for External Innovation, highlighted the significance of the collaboration. He said “Continuing our collaboration with BioCurate renews our bond with their internationally renowned team, and our connection with the thriving ‘Parkville Precinct’ medical research community. We look forward to identifying promising projects for collaboration, and jointly pursuing the potential to create transformational new therapies for patients.”

Reimagining healthcare across the entire patient journey: Health Industry Hub^TM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.